Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.

The purpose of this systematic review was to evaluate the safety and efficacy of autologous hematopoietic cell transplantation in patients with progressive multiple sclerosis (MS) refractory to conventional medical treatment.